Eribulin and Lenvatinib in Advanced Solid Tumors

NCT02640508 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Cancer
Solid Tumor

Interventions

DRUG: Eribulin
DRUG: Lenvatinib

Sponsor

Virginia G. Kaklamani

Collaborators

[object Object]